Vertex Pharmaceuticals Incorporated Financial Ratios — VRTX

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	4.58	-11.99	-37.78	-60.75	-55.22	-10.69	16.54	64.88	22.37	36.71	24.93	27.67	22.99	-3.15	22.54
Return on Assets (%)	1.51	-4.31	-17.53	-31.74	-23.02	-4.15	8.18	42.83	16.16	27.02	18.6	21.04	17.71	-2.37	16.41
Return on Capital (%)	3.6	- -	- -	- -	- -	- -	- -	- -	20.84	33.76	23.15	26	22.02	-3.29	20.41
Return on Invested Capital (%)	12.39	- -	- -	- -	- -	- -	- -	- -	17.07	30.18	22.7	25.45	18.69	2.73	19.83
Gross Margin (%)	94.29	81.67	89.25	89.49	87.94	87.64	88.95	86.56	86.84	88.14	88.06	87.9	87.21	86.11	86.24
EBITDA Margin (%)	18.2	5.68	-8.93	-99.62	-38.97	4.26	18.25	24.16	31.44	48	38.35	49.25	40.14	-0.24	39.7
Operating Margin (%)	15.72	3.18	-12.92	-110.52	-45.01	0.66	15.78	21.79	28.87	46.24	36.69	47.59	38.31	-2.12	37.95
Incremental Operating Margin (%)	72.3	-148.71	- -	- -	- -	71.04	48.52	48.51	48.25	81.62	-6.6	108.45	-50.03	7.6	487.95
Pretax Margin (%)	4.28	2.1	-51.65	-126.61	-54.03	-3.96	-0.63	19.7	33.51	50.23	36.05	47.39	44.38	2.25	38.69
Profit Margin (%)	2.1	-7.01	-36.72	-127.25	-53.89	-6.58	10.59	68.8	28.27	43.7	30.92	37.2	36.68	-4.86	32.94
Net Income to Common Margin (%)	2.1	-7.01	-36.72	-127.25	-53.89	-6.58	10.59	68.8	28.27	43.7	30.92	37.2	36.68	-4.86	32.94
Effective Tax Rate (%)	31.87	- -	- -	- -	- -	- -	- -	- -	15.64	13	14.22	21.51	17.36	315.53	14.86
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	4.58	-11.99	-37.78	-60.75	-55.22	-10.69	16.54	64.88	22.37	36.71	24.93	27.67	22.99	-3.15	22.54

Credit (USD)

Credit Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	456	697	507	825	826	841	606	587	662	932	967	900	808	1,744	2,030
ST Debt	- -	14	17	32	87	319	23	5	39	42	80	89	84	87	77
LT Debt	456	683	490	793	739	521	584	582	623	890	887	810	725	1,657	1,953
Total Debt/EBITDA	1.78	8.03	-4.68	-1.43	-2.05	11.58	1.34	0.8	0.51	0.31	0.33	0.2	0.2	-66.58	0.43
Net Debt/EBITDA	-0.29	-1.03	5.26	0.57	1.04	-12.18	-3.67	-3.6	-2.38	-2.01	-2.34	-2.39	-2.62	174.41	-1.07
Total Debt/EBIT	2.06	14.35	-3.24	-1.29	-1.78	75.08	1.54	0.88	0.55	0.32	0.35	0.21	0.21	-7.47	0.45
Net Debt/EBIT	-0.34	-1.84	3.64	0.52	0.9	-78.94	-4.24	-3.99	-2.59	-2.09	-2.45	-2.47	-2.74	19.58	-1.12
EBITDA to Interest Expense	6.81	5.77	-4.72	-7.94	-4.78	0.89	6.55	10.16	22.37	51.18	47.23	80.26	89.83	-0.86	358.21
EBITDA-CapEx/Interest Expense	4.3	1.04	-6.96	-8.64	-5.32	0.2	2.81	8.84	21.09	46.72	43.41	76.52	83.98	-16.72	325.31
EBIT to Interest Expense	5.88	3.23	-6.83	-8.8	-5.52	0.14	5.67	9.16	20.55	49.3	45.19	77.55	85.72	-7.63	342.44
Interest Expense	38	15	23	73	84	81	69	72	58	58	62	55	44	31	13
Common Equity/Total Assets	35.7	36.21	58.49	46.05	37.62	39.93	57.21	71.01	73.15	73.92	75.19	76.65	77.34	72.82	72.79
Long-Term Debt/Equity (%)	49.11	57.13	36.1	72.34	67.61	38.96	28.59	13.11	10.24	10.24	8.78	5.82	4.12	10.1	10.46
Long-Term Debt/Capital (%)	32.93	36.1	26.29	41.27	38.51	23.93	22.04	11.58	9.23	9.25	8.02	5.47	3.94	9.13	9.44
Long-Term Debt/Total Assets (%)	20.68	24.76	21.12	33.96	29.59	18	16.47	9.31	7.49	7.57	6.6	4.46	3.19	7.35	7.62
Total Debt/Equity (%)	49.11	58.28	37.35	75.26	75.55	62.83	29.69	13.23	10.87	10.73	9.58	6.47	4.6	10.63	10.88
Total Debt/Capital (%)	32.93	36.82	27.19	42.94	43.04	38.59	22.9	11.68	9.81	9.69	8.74	6.07	4.4	9.61	9.81
Total Debt/Total Assets (%)	20.68	25.26	21.84	35.33	33.07	29.02	17.1	9.4	7.95	7.93	7.2	4.96	3.56	7.74	7.92
Net Debt to Equity	-8.11	-7.48	-41.97	-30.15	-38.37	-66.06	-81.55	-59.75	-51.1	-68.93	-67.28	-75.5	-58.98	-27.85	-27.24
Net Debt/Capital (%)	-8.29	-6.37	-44.01	-25.5	-34.82	-88.84	-169.37	-111.73	-85.48	-164.94	-159.04	-243.8	-129.3	-33.64	-32.57
EBITDA	257	87	-108	-578	-402	73	454	736	1,309	2,979	2,905	4,398	3,962	-26	4,764
EBITDA-CapEx	162	16	-160	-629	-448	16	195	641	1,234	2,719	2,670	4,194	3,703	-512	4,327
Operating Income (Loss)	222	49	-157	-641	-465	11	393	664	1,202	2,869	2,779	4,250	3,780	-233	4,554

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	2.47	3.05	3.68	3.77	2.06	1.81	2.59	2.83	2.85	3.55	3.51	3.93	3.16	1.72	1.71
Current Ratio	3.39	3.67	3.99	4.2	2.78	2.31	3.28	3.43	3.61	4.33	4.46	4.83	3.99	2.69	2.9
Quick Ratio	2.94	3.39	3.92	4.01	2.43	2.11	3.07	3.19	3.33	4.02	4.04	4.46	3.6	2.17	2.24
CFO/Avg Current Liab	0.33	0.65	-0.15	-1.5	-0.84	0.36	1.06	1.32	1.28	2.03	1.32	1.69	1.12	-0.14	0.98
Common Equity/Total Assets	35.7	36.21	58.49	46.05	37.62	39.93	57.21	71.01	73.15	73.92	75.19	76.65	77.34	72.82	72.79
Long-Term Debt/Equity (%)	49.11	57.13	36.1	72.34	67.61	38.96	28.59	13.11	10.24	10.24	8.78	5.82	4.12	10.1	10.46
Long-Term Debt/Capital (%)	32.93	36.1	26.29	41.27	38.51	23.93	22.04	11.58	9.23	9.25	8.02	5.47	3.94	9.13	9.44
Long-Term Debt/Total Assets (%)	20.68	24.76	21.12	33.96	29.59	18	16.47	9.31	7.49	7.57	6.6	4.46	3.19	7.35	7.62
Total Debt/Equity (%)	49.11	58.28	37.35	75.26	75.55	62.83	29.69	13.23	10.87	10.73	9.58	6.47	4.6	10.63	10.88
Total Debt/Capital (%)	32.93	36.82	27.19	42.94	43.04	38.59	22.9	11.68	9.81	9.69	8.74	6.07	4.4	9.61	9.81
Total Debt/Total Assets (%)	20.68	25.26	21.84	35.33	33.07	29.02	17.1	9.4	7.95	7.93	7.2	4.96	3.56	7.74	7.92
CFO/Total Liabilities	11.27	17.13	-6.3	-46.27	-26.01	15.15	56.19	70.15	70.27	106.15	79.32	97.44	68.69	-8.04	52.05
CFO/CapEx	1.52	3.76	-1.18	-11.19	-8.07	4.17	3.26	13.31	20.81	12.52	11.25	20.18	13.69	-1.01	8.3
Altman's Z-Score	2.27	2.6	9.33	10.95	10.1	5.27	14.81	14.71	16.64	14.38	12.57	13.22	14.58	11.64	12.17

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	14.42	9.36	10.6	7.19	8.27	9.1	10.33	8.82	7.98	8.17	7.49	6.93	6.57	6.95	6.55
Days Sales Outstanding	25.31	39.01	34.45	50.77	44.16	40.12	35.32	41.38	45.73	44.67	48.72	52.7	55.58	52.54	55.69
Inventory Turnover	1.43	3.92	5.84	2.71	2.83	3.12	2.9	3.47	3.75	3.28	2.85	2.66	2.1	1.57	1.14
Days Inventory Outstanding	254.87	93.17	62.49	134.64	129.06	116.9	125.66	105.25	97.23	111.12	127.94	137.46	173.42	231.83	319.64
Accounts Payable Turnover	3.49	2.25	1.51	1.29	2.06	3.39	4.57	4.56	5.95	7	5.58	4.76	4.61	5.13	4.88
Accounts Payable Turnover Days	104.52	162.23	241.21	283.12	176.77	107.82	79.91	79.98	61.33	52.14	65.43	76.65	79.24	71.09	74.85
Cash Conversion Cycle	175.67	-30.05	-144.27	-97.7	-3.55	49.2	81.08	66.65	81.64	103.65	111.24	113.51	149.76	213.29	300.48
Inventory to Cash Days	-229.56	-54.17	-28.05	-83.87	-84.9	-76.78	-90.34	-63.87	-51.5	-66.45	-79.22	-84.76	-117.84	-179.29	-263.95
Inventories	112	30	14	31	57	78	112	124	168	281	353	461	739	1,205	1,687
Raw Materials	32	4	- -	9	9	6	21	10	26	46	42	38	79	252	260
Work In Process	47	11	10	21	41	57	74	88	107	161	224	261	525	769	1,197
Finished Goods	33	15	4	2	8	15	17	27	34	73	87	162	135	185	230
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	6,951	9,104	17,371	28,722	30,993	18,292	37,953	42,285	56,707	61,422	55,884	74,220	104,854	103,470	115,149
- Cash & Cash Equivalents	475	489	569	625	715	1,184	1,665	2,650	3,109	5,988	6,795	10,504	10,369	4,570	5,085
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	142	197	- -	21	154	182	14	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	456	697	507	825	826	841	606	587	662	932	967	900	808	1,744	2,030
Enterprise Value	6,580	8,677	16,412	28,181	30,930	17,880	36,484	39,703	53,560	55,695	49,326	64,341	94,444	99,098	110,572
Total Capital	1,384	1,893	1,863	1,921	1,920	2,179	2,649	5,022	6,747	9,619	11,067	14,812	18,389	18,154	20,696
Total Debt/Capital (%)	32.93	36.82	27.19	42.94	43.04	38.59	22.9	11.68	9.81	9.69	8.74	6.07	4.4	9.61	9.81
Total Debt / EV	0.07	0.08	0.03	0.03	0.03	0.05	0.02	0.01	0.01	0.02	0.02	0.01	0.01	0.02	0.02
EV/Sales	4.66	5.68	13.54	48.55	29.96	10.5	14.66	13.03	12.87	8.97	6.51	7.2	9.57	8.99	9.21
EV/EBITDA	25.63	100.01	- -	- -	- -	246.3	80.32	53.92	40.92	18.7	16.98	14.63	23.84	21.62	23.21
EV/EBIT	29.68	178.64	- -	- -	- -	1,596.72	92.88	59.8	44.56	19.41	17.75	15.14	24.98	22.64	24.28
EV/Cash Flow to Firm	38.84	30.66	- -	- -	- -	52.95	82.88	26.08	33.09	16.86	18.29	15.42	26.43	- -	30.35
EV/Free Cash Flow to Firm	24.92	24.5	1,789.78	- -	- -	45.35	52.15	24.54	31.62	15.63	16.83	14.7	24.65	- -	27.1
Diluted Market Cap	6,934	8,881	16,711	27,954	30,364	18,026	37,948	42,950	57,074	62,251	57,074	74,823	105,995	103,856	116,967
Diluted Enterprise Value	7,057	9,285	16,648	28,175	30,629	17,864	36,903	40,886	54,627	57,195	51,246	65,219	96,434	101,031	113,913
EV per Share	31.44	39.93	70.2	116.56	125.58	72.01	144.06	155.59	206.8	214.3	193.83	250.34	366.49	385.69	435.34
TTM Sales	1,411	1,527	1,212	580	1,032	1,702	2,489	3,048	4,163	6,206	7,574	8,931	9,869	11,020	12,001
TTM EBITDA	257	87	-108	-578	-402	73	454	736	1,309	2,979	2,905	4,398	3,962	-26	4,764
TTM Operating Income	222	49	-157	-641	-465	11	393	664	1,202	2,869	2,779	4,250	3,780	-233	4,554
TTM Cash Flow to Firm	169	283	-42	-500	-277	338	440	1,522	1,619	3,304	2,696	4,173	3,574	-559	3,643
TTM Free Cash Flow to Firm	264	354	9	-448	-231	394	700	1,618	1,694	3,564	2,931	4,378	3,832	-73	4,080

Multiples (USD)

Valuation Multiples API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	29.1	26.2	-1,802.06	-53.56	-94.85	61.59	34.36	31.45	34.7	17.72	19.83	17.26	27.92	-14,424.49	28.75
EV/EBIT	29.68	178.64	- -	- -	- -	1,596.72	92.88	59.8	44.56	19.41	17.75	15.14	24.98	22.64	24.28
Enterprise Value	6,580	8,677	16,412	28,181	30,930	17,880	36,484	39,703	53,560	55,695	49,326	64,341	94,444	99,098	110,572
Low Price	26.5	32.04	42.72	59.79	97.45	71.46	73.34	144.07	160.95	197.47	176.36	214.66	282.21	377.85	362.5
EV/Sales	4.66	5.68	13.54	48.55	29.96	10.5	14.66	13.03	12.87	8.97	6.51	7.2	9.57	8.99	9.21
EV/EBITDA	25.63	100.01	- -	- -	- -	246.3	80.32	53.92	40.92	18.7	16.98	14.63	23.84	21.62	23.21
Price/Earnings	230.08	- -	- -	- -	- -	- -	141.54	20.1	47.77	22.65	24.16	22.26	28.97	- -	29.32
Price/Earnings Average	305.01	-93.83	-34.38	-28.51	-53.69	-192.56	119.86	20.3	40.3	24.1	22.49	21.17	24.15	-216.95	28.68
Price/Earnings High	407.86	-130.89	-45.46	-39.62	-62.22	-272.87	158.54	23.64	49.23	29.33	26.74	25.04	29.4	-250.33	33.61
Price/Earnings Low	183.59	-63.45	-21.59	-19.05	-42.27	-156.05	69.27	17.47	35.11	18.92	19.4	16.55	20.09	-181.94	23.45
Price/Book Value	8.83	9.11	12.81	26.72	32.97	15.82	18.71	9.53	9.32	7.07	5.53	5.33	5.96	6.31	6.17
Price/Book Value Average	11.71	10.3	11.73	20.12	32.44	18.93	15.84	9.63	7.86	7.53	5.15	5.07	4.97	7.05	6.03
Price/Book Value High	15.66	14.37	15.51	27.97	37.59	26.83	20.96	11.21	9.6	9.16	6.12	6	6.05	8.14	7.07
Price/Book Value Low	7.05	6.97	7.36	13.45	25.54	15.34	9.16	8.29	6.85	5.91	4.44	3.97	4.14	5.92	4.93
Price/Tangible Book Value	75.27	29.88	13.11	28.55	51.21	22.26	19.47	9.64	12.11	8.43	6.43	6.07	6.7	7.14	6.71
Price/Tangible Book Value Average	99.78	33.79	12	21.5	50.38	26.64	16.49	9.74	10.22	8.97	5.98	5.77	5.58	7.99	6.57
Price/Tangible Book Value High	133.42	47.14	15.87	29.88	58.38	37.75	21.81	11.34	12.48	10.92	7.11	6.83	6.8	9.22	7.69
Price/Tangible Book Value Low	60.06	22.85	7.54	14.37	39.66	21.59	9.53	8.38	8.9	7.05	5.16	4.51	4.65	6.7	5.37
Price/Sales	4.82	5.82	13.79	48.16	29.41	10.59	14.99	13.83	13.5	9.9	7.47	8.28	10.62	9.42	9.66
Price/Sales Average	6.39	6.58	12.62	36.28	28.94	12.68	12.69	13.97	11.39	10.53	6.96	7.87	8.86	10.54	9.45
Price/Sales High	8.55	9.17	16.69	50.41	33.53	17.96	16.79	16.26	13.92	12.82	8.27	9.31	10.78	12.17	11.07
Price/Sales Low	3.85	4.45	7.93	24.24	22.78	10.27	7.33	12.02	9.93	8.27	6	6.16	7.37	8.84	7.72
Price/Cash Flow	47.34	33.16	-275.45	-48.78	-83.09	76.35	44.14	33.17	35.82	18.88	21.41	17.91	29.64	-210.83	31.92
Price/Cash Flow Average	62.76	37.49	-252.2	-36.74	-81.74	91.39	37.38	33.51	30.22	20.09	19.93	17.03	24.71	-235.89	31.23
Price/Cash Flow High	83.92	52.31	-333.51	-51.06	-94.73	129.5	49.44	39.02	36.92	24.45	23.69	20.14	30.09	-272.18	36.59
Price/Cash Flow Low	37.78	25.35	-158.38	-24.55	-64.35	74.06	21.6	28.84	26.33	15.77	17.19	13.31	20.56	-197.82	25.52
Price/Free Cash Flow Average	38.57	29.63	-1,649.98	-40.34	-93.31	73.73	29.1	31.77	29.28	18.86	18.46	16.41	23.28	-16,138.87	28.12
Price/Free Cash Flow High	51.58	41.33	-2,181.88	-56.06	-108.13	104.47	38.49	36.99	35.77	22.95	21.94	19.41	28.34	-18,621.81	32.95
Price/Free Cash Flow Low	23.22	20.03	-1,036.12	-26.96	-73.46	59.74	16.82	27.34	25.51	14.8	15.92	12.83	19.37	-13,534.38	22.98
EV/Sales Average	6.62	7.01	13.07	37.65	29.79	12.77	12.49	13.34	10.91	9.72	6.1	6.83	7.89	10.25	9.13
EV/Sales High	8.82	9.67	17.3	52.18	34.48	18.13	16.66	15.64	13.45	12	7.39	8.27	9.82	11.86	10.74
EV/Sales Low	4.02	4.82	8.19	25.29	23.51	10.33	7.04	11.39	9.43	7.46	5.16	5.1	6.4	8.55	7.42
EV/EBITDA Average	36.37	123.32	-146.38	-37.8	-76.44	299.39	68.45	55.21	34.68	20.25	15.9	13.86	19.65	-4,310.77	23
EV/EBITDA High	48.47	170.2	-193.76	-52.37	-88.48	425.18	91.29	64.74	42.78	25.01	19.28	16.79	24.45	-4,990.57	27.06
EV/EBITDA Low	22.08	84.9	-91.71	-25.38	-60.32	242.19	38.59	47.12	29.98	15.53	13.44	10.36	15.94	-3,597.7	18.68
EV/EBIT Average	42.12	220.29	-101.17	-34.07	-66.18	1,940.91	79.15	61.23	37.77	21.02	16.62	14.35	20.59	-483.9	24.06
EV/EBIT High	56.13	304.03	-133.91	-47.21	-76.61	2,756.39	105.55	71.8	46.59	25.96	20.15	17.38	25.62	-560.21	28.31
EV/EBIT Low	25.57	151.66	-63.38	-22.88	-52.23	1,570.1	44.62	52.26	32.64	16.12	14.05	10.72	16.71	-403.85	19.55
Last Price	33.21	41.9	74.3	118.8	125.83	73.67	149.86	165.71	218.95	236.34	219.6	288.78	406.89	402.7	453.36
High Price	58.87	66.1	89.96	124.35	143.45	124.96	167.86	194.92	225.66	306.08	242.99	324.75	413	519.88	519.68
Enterprise Value Average	9,337	10,700	15,842	21,855	30,754	21,734	31,094	40,654	45,399	60,320	46,196	60,970	77,841	112,942	109,580
Enterprise Value High	12,444	14,767	20,969	30,284	35,598	30,866	41,465	47,675	55,997	74,491	56,008	73,860	96,867	130,753	128,940
Enterprise Value Low	5,669	7,366	9,925	14,676	24,268	17,582	17,528	34,699	39,237	46,264	39,052	45,566	63,163	94,260	89,018

Shares Outstanding	209	217	234	242	246	248	253	255	259	260	254	257	258	257	254
Diluted Weighted Avg Shares	209	212	225	235	241	245	253	259	261	263	260	259	260	258	258
Basic Weighted Avg Shares	205	212	225	235	241	245	249	254	257	260	258	256	258	258	256
Revenue per Share	6.88	7.2	5.39	2.47	4.28	6.96	10	11.98	16.21	23.88	29.39	34.87	38.3	42.73	46.94
EBITDA per Share	1.25	0.41	-0.48	-2.46	-1.67	0.3	1.83	2.9	5.1	11.46	11.27	17.17	15.37	-0.1	18.63
Operating Income per Share	1.08	0.23	-0.7	-2.73	-1.93	0.05	1.58	2.61	4.68	11.04	10.78	16.59	14.67	-0.91	17.81
Basic EPS, GAAP	0.14	-0.5	-1.98	-3.14	-2.31	-0.46	1.06	8.25	4.58	10.44	9.09	12.97	14.05	-2.08	15.46
Basic EPS from Cont Ops	0.2	0.15	-2.24	-3.15	-2.44	-0.34	0.37	8.21	4.58	10.44	9.09	12.97	14.05	-2.08	15.46
Diluted EPS, GAAP	0.14	-0.5	-1.98	-3.14	-2.31	-0.46	1.04	8.09	4.51	10.3	9.01	12.82	13.89	-2.08	15.32
Diluted EPS from Cont Ops	0.2	0.15	-2.24	-3.15	-2.44	-0.34	0.36	8.05	4.51	10.3	9.01	12.82	13.89	-2.08	15.32
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	0.7	1.26	-0.27	-2.44	-1.51	0.96	3.4	5	6.11	12.52	10.26	16.13	13.73	-1.91	14.2
Free Cash Flow per Basic Share	0.24	0.93	-0.5	-2.65	-1.7	0.73	2.35	4.62	5.82	11.52	9.35	15.33	12.72	-3.79	12.49
Cash & Equivalents per Share	4.63	6.08	6.27	5.74	4.23	5.78	8.25	12.42	14.7	25.62	29.57	41.94	43.53	23.8	26.02
Book Value per Share	3.76	4.6	5.8	4.45	3.82	4.66	8.01	17.38	23.5	33.42	39.69	54.13	68.22	63.87	73.49
Tangible Book Value per Share	0.44	1.4	5.67	4.16	2.46	3.31	7.7	17.18	18.08	28.03	34.18	47.55	60.74	56.42	67.54

Vertex Pharmaceuticals Incorporated

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)